Simultaneously, ITGA9 is obviously up-regulated in already-developed drug-resistant colon cancer cells, whereas α9 is reported to be a promising target candidate for overcoming methotrexate resistance in colon cancer (95). The gene discussed is IGKV1D-22; the disease is malignant colon neoplasm.